category	number_of_genes	p_value	fdr	description
NetworkNeighborAL	67	3.1900000000000005e-123	1.46e-119	DNA repair pathways, full network, and HDR through Homologous Recombination (HRR)
NetworkNeighborAL	63	2.43e-117	3.7099999999999996e-114	Mixed, incl. Fanconi anemia pathway, and DNA repair complex
NetworkNeighborAL	64	4.23e-117	4.84e-114	DNA repair pathways, full network, and HDR through Homologous Recombination (HRR)
Process	85	8.09e-118	1.27e-113	DNA metabolic process
Process	79	7.430000000000001e-116	5.83e-112	DNA repair
RCTM	72	2.01e-112	4.6e-109	DNA Repair
NetworkNeighborAL	60	2.65e-111	2.43e-108	DNA repair pathways, full network, and HDR through Homologous Recombination (HRR)
Process	82	1.2800000000000001e-110	6.67e-107	Cellular response to DNA damage stimulus
Keyword	68	4.42e-97	2.9699999999999996e-94	DNA damage
RCTM	54	9.01e-94	1.03e-90	HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)
RCTM	55	1.2699999999999999e-90	7.23e-88	DNA Double-Strand Break Repair
Keyword	61	2.2500000000000002e-86	7.56e-84	DNA repair
RCTM	45	3.99e-82	1.8200000000000003e-79	HDR through Homologous Recombination (HRR)
NetworkNeighborAL	43	6.209999999999999e-82	4.7300000000000006e-79	Homologous DNA Pairing and Strand Exchange, and Response to intra-S DNA damage checkpoint signaling
NetworkNeighborAL	45	5.19e-80	3.39e-77	Diseases of DNA repair, and DNA repair complex
COMPARTMENTS	72	8.21e-80	1.89e-76	Chromosome
RCTM	39	2.7099999999999998e-74	1.0300000000000001e-71	Homologous DNA Pairing and Strand Exchange
PMID	49	2.85e-78	1.25e-71	(2012) Exonuclease 1 (EXO1) gene variation and melanoma risk.
RCTM	37	1.56e-70	5.1e-68	Presynaptic phase of homologous DNA pairing and strand exchange
RCTM	37	2.9999999999999995e-70	8.56e-68	Defective homologous recombination repair (HRR) due to BRCA2 loss of function
Process	49	5.25e-69	8.23e-66	DNA recombination
PMID	44	1.2999999999999998e-69	2.85e-63	(2010) The DNA damage response: making it safe to play with knives.
RCTM	34	3e-64	6.23e-62	HDR through Single Strand Annealing (SSA)
WikiPathways	38	9.450000000000001e-64	7.379999999999999e-61	DNA IR-damage and cellular response via ATR
Process	45	9.13e-64	1.1000000000000001e-60	Double-strand break repair
KEGG	35	5.41e-63	1.8199999999999998e-60	Fanconi anemia pathway
WikiPathways	40	2.27e-62	8.88e-60	DNA repair pathways, full network
RCTM	37	8.51e-62	1.6200000000000001e-59	Processing of DNA double-strand break ends
PMID	40	6.78e-65	9.910000000000001e-59	(2015) DNA repair mechanisms in cancer development and therapy.
RCTM	32	1.43e-60	2.5100000000000002e-58	Impaired BRCA2 binding to RAD51
Component	72	7.709999999999999e-60	1.58e-56	Chromosome
PMID	35	2.46e-62	2.7e-56	(2020) The FANCBRCA Pathway Releases Replication Blockades by Eliminating DNA Interstrand Cross-Links.
PMID	39	7.38e-62	6.47e-56	(2014) Emergence and evolutionary analysis of the human DDR network: implications in comparative genomics and downstream analyses.
RCTM	35	4.42e-58	7.210000000000001e-56	G2/M DNA damage checkpoint
PMID	35	1.05e-61	7.66e-56	(2017) The Role of PALB2 in the DNA Damage Response and Cancer Predisposition.
PMID	35	1.05e-61	7.66e-56	(2016) Cellular response to DNA interstrand crosslinks: the Fanconi anemia pathway.
PMID	35	1.68e-61	9.190000000000001e-56	(2019) Holding All the Cards-How Fanconi Anemia Proteins Deal with Replication Stress and Preserve Genomic Stability.
PMID	37	1.7899999999999997e-61	9.190000000000001e-56	(2013) DNA damage tolerance: a double-edged sword guarding the genome.
NetworkNeighborAL	31	4.76e-58	2.72e-55	Resolution of D-loop Structures through Holliday Junction Intermediates, and RIDDLE syndrome
PMID	37	3.04e-60	1.3299999999999997e-54	(2021) DNA folds threaten genetic stability and can be leveraged for chemotherapy.
PMID	34	9.67e-60	3.8599999999999994e-54	(2019) The Fanconi Anemia Pathway in Cancer.
PMID	33	2.84e-59	1.04e-53	(2016) Interplay between Fanconi anemia and homologous recombination pathways in genome integrity.
Process	37	1.43e-56	1.4999999999999999e-53	Recombinational repair
Process	41	3.2500000000000003e-56	3.19e-53	DNA replication
PMID	34	2.21e-58	7.44e-53	(2017) Maintenance of genome stability by Fanconi anemia proteins.
Process	36	4.71e-55	4.35e-52	Double-strand break repair via homologous recombination
PMID	31	1.62e-57	5.07e-52	(2017) A never-ending story: the steadily growing family of the FA and FA-like genes.
PMID	35	2.68e-57	7.84e-52	(2019) DNA Damage Response Pathways in Dinoflagellates.
RCTM	37	2.62e-53	3.99e-51	G2/M Checkpoints
PMID	35	1.04e-55	2.85e-50	(2021) Mass spectrometry-based protein-protein interaction techniques and their applications in studies of DNA damage repair.
RCTM	28	3.39e-52	4.84e-50	Resolution of D-loop Structures through Holliday Junction Intermediates
PMID	35	2.6499999999999998e-55	6.83e-50	(2019) Tissue specificity of DNA damage response and tumorigenesis.
PMID	34	3.13e-54	7.63e-49	(2014) DNA repair in cancer: emerging targets for personalized therapy.
PMID	34	4.31e-54	9.94e-49	(2018) Integrating the DNA damage and protein stress responses during cancer development and treatment.
Component	82	4.56e-51	4.67e-48	Nucleoplasm
PMID	33	3.4299999999999997e-53	7.519999999999999e-48	(2016) The multifaceted influence of histone deacetylases on DNA damage signalling and DNA repair.
PMID	29	4.17e-53	8.71e-48	(2017) Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia.
RCTM	32	8.06e-50	1.02e-47	Regulation of TP53 Activity through Phosphorylation
PMID	30	5.45e-53	1.09e-47	(2017) DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway.
PMID	29	1.05e-51	2e-46	(2015) Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy.
PMID	32	2.64e-51	4.8199999999999996e-46	(2018) Ubiquitylation at the Fork: Making and Breaking Chains to Complete DNA Replication.
PMID	29	2.85e-51	4.8199999999999996e-46	(2012) Rescue of replication failure by Fanconi anaemia proteins.
PMID	32	2.64e-51	4.8199999999999996e-46	(2017) Around and beyond 53BP1 Nuclear Bodies.
PMID	30	3.23e-51	5.25e-46	(2019) PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms.
PMID	30	3.23e-51	5.25e-46	(2020) Canonical and Noncanonical Roles of Fanconi Anemia Proteins: Implications in Cancer Predisposition.
PMID	32	5.05e-51	7.64e-46	(2021) miR-27b-3p a Negative Regulator of DSB-DNA Repair.
PMID	36	5.96e-51	8.71e-46	(2021) Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies.
PMID	30	1.12e-50	1.58e-45	(2020) DNA Repair Syndromes and Cancer: Insights Into Genetics and Phenotype Patterns.
PMID	31	1.32e-50	1.81e-45	(2020) Protective Mechanisms Against DNA Replication Stress in the Nervous System.
COMPARTMENTS	76	2.1199999999999998e-48	2.4399999999999998e-45	Intracellular non-membrane-bounded organelle
COMPARTMENTS	83	3.5899999999999996e-48	2.4399999999999998e-45	Nucleus
RCTM	48	3.29e-47	3.96e-45	Cell Cycle
PMID	28	3.19e-50	4.2399999999999995e-45	(2015) What is the DNA repair defect underlying Fanconi anemia?
PMID	31	3.75e-50	4.84e-45	(2019) Proteolytic control of genome integrity at the replication fork.
PMID	29	7.2700000000000005e-50	9.109999999999999e-45	(2021) Mind the replication gap.
PMID	28	8.9e-50	1.0800000000000001e-44	(2011) DNA interstrand crosslink repair and cancer.
RCTM	26	1.31e-46	1.5e-44	Fanconi Anemia Pathway
RCTM	38	2.77e-46	3.01e-44	Cell Cycle Checkpoints
PMID	29	2.62e-49	3.1000000000000003e-44	(2020) Fanconi anemia pathway as a prospective target for cancer intervention.
PMID	30	4.99e-49	5.76e-44	(2013) Human single-stranded DNA binding proteins are essential for maintaining genomic stability.
PMID	29	1.9599999999999998e-48	2.21e-43	(2022) Type-I Interferon Signaling in Fanconi Anemia.
PMID	28	2.44e-48	2.68e-43	(2020) Under-Replicated DNA: The Byproduct of Large Genomes?
PMID	28	2.44e-48	2.68e-43	(2009) Choreography of recombination proteins during the DNA damage response.
PMID	32	3.87e-48	4.04e-43	(2021) Zebrafish Cancer Predisposition Models.
COMPARTMENTS	28	2.76e-45	1.2699999999999999e-42	Replication fork
PMID	29	1.2900000000000001e-47	1.3099999999999999e-42	(2013) DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy.
PMID	32	2.27e-47	2.26e-42	(2019) DNA damage response and repair in perspective: Aedes aegypti, Drosophila melanogaster and Homo sapiens.
PMID	26	2.59e-47	2.5199999999999998e-42	(2021) Implications of the germline variants of DNA damage response genes detected by cancer precision medicine for radiological risk communication and cancer therapy decisions.
PMID	28	3.13e-47	2.98e-42	(2009) Fanconi anemia proteins, DNA interstrand crosslink repair pathways, and cancer therapy.
Process	32	5.04e-45	4.1599999999999994e-42	DNA-templated DNA replication
PMID	25	5.93e-47	5.529999999999999e-42	(2015) Update of the human and mouse Fanconi anemia genes.
COMPARTMENTS	62	1.82e-44	6.979999999999999e-42	Nuclear lumen
PMID	27	7.980000000000001e-47	7.289999999999999e-42	(2021) Shaping the BRCAness mutational landscape by alternative double-strand break repair, replication stress and mitotic aberrancies.
PMID	25	1.12e-46	1e-41	(2016) Novel insights into RAD51 activity and regulation during homologous recombination and DNA replication.
PMID	27	1.25e-46	1.1e-41	(2018) Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.
PMID	25	2.0799999999999998e-46	1.79e-41	(2021) An update on Fanconi anemia: Clinical, cytogenetic and molecular approaches (Review).
PMID	26	3.6599999999999996e-46	3.08e-41	(2014) DNA double-strand break repair pathway choice and cancer.
PMID	26	3.6599999999999996e-46	3.08e-41	(2018) Rare Genetic Diseases with Defects in DNA Repair: Opportunities and Challenges in Orphan Drug Development for Targeted Cancer Therapy.
PMID	25	3.8e-46	3.08e-41	(2017) Germline and somatic mutations in homologous recombination genes among Chinese ovarian cancer patients detected using next-generation sequencing.
PMID	27	7.07e-46	5.64e-41	(2022) Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy.
RCTM	23	7.49e-43	7.43e-41	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
PMID	26	9.8e-46	7.68e-41	(2010) BRCA1 and its toolbox for the maintenance of genome integrity.
PMID	29	1.39e-45	1.07e-40	(2020) Chromosome Instability in Fanconi Anemia: From Breaks to Phenotypic Consequences.
PMID	25	2.1299999999999998e-45	1.61e-40	(2013) The BLM dissolvasome in DNA replication and repair.
Process	32	2.4400000000000002e-43	1.91e-40	Cell cycle checkpoint signaling
PMID	29	3.46e-45	2.57e-40	(2021) Fanconi Anemia Pathway Genes Advance Cervical Cancer via Immune Regulation and Cell Adhesion.
PMID	25	3.68e-45	2.6899999999999997e-40	(2013) A novel interplay between the Fanconi anemia core complex and ATR-ATRIP kinase during DNA cross-link repair.
PMID	27	5.3000000000000003e-45	3.81e-40	(2019) Advances in understanding DNA processing and protection at stalled replication forks.
KEGG	24	3.7699999999999996e-42	6.34e-40	Homologous recombination
PMID	24	9.22e-45	6.52e-40	(2016) FANCM interacts with PCNA to promote replication traverse of DNA interstrand crosslinks.
PMID	28	1.0600000000000001e-44	7.35e-40	(2019) The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies.
Process	54	1.02e-42	7.609999999999999e-40	Cell cycle
PMID	27	1.14e-44	7.789999999999999e-40	(2021) The emerging determinants of replication fork stability.
PMID	27	1.14e-44	7.789999999999999e-40	(2021) RAD52: Paradigm of Synthetic Lethality and New Developments.
PMID	28	1.46e-44	9.72e-40	(2020) Bacterial Genotoxin-Induced DNA Damage and Modulation of the Host Immune Microenvironment.
Component	26	2.4799999999999996e-42	1.27e-39	Replication fork
PMID	29	1.96e-44	1.28e-39	(2019) Deleterious Mutations in DNA Repair Gene FANCC Exist in BRCA12-Negative Chinese Familial Breast andor Ovarian Cancer Patients.
PMID	26	2.35e-44	1.51e-39	(2009) The Fanconi anemia protein interaction network: casting a wide net.
PMID	27	2.39e-44	1.51e-39	(2018) Germline Pathogenic Variants in Homologous Recombination and DNA Repair Genes in an Asian Cohort of Young-Onset Colorectal Cancer.
PMID	26	2.35e-44	1.51e-39	(2020) The Regulation of Homologous Recombination by Helicases.
PMID	27	3.44e-44	2.12e-39	(2021) Genomic Instability and Cancer Risk Associated with Erroneous DNA Repair.
PMID	26	3.5800000000000003e-44	2.18e-39	(2013) DNA helicases involved in DNA repair and their roles in cancer.
PMID	25	4.81e-44	2.89e-39	(2015) FANCI Regulates Recruitment of the FA Core Complex at Sites of DNA Damage Independently of FANCD2.
RCTM	22	3.19e-41	3.04e-39	Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function
RCTM	22	3.19e-41	3.04e-39	Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
RCTM	22	3.19e-41	3.04e-39	Impaired BRCA2 binding to PALB2
RCTM	22	3.19e-41	3.04e-39	Defective homologous recombination repair (HRR) due to BRCA1 loss of function
PMID	27	7.01e-44	4.16e-39	(2015) Hsp90: A New Player in DNA Repair?
PMID	25	7.79e-44	4.55e-39	(2014) Abundance of the Fanconi anaemia core complex is regulated by the RuvBL1 and RuvBL2 AAA+ ATPases.
PMID	25	7.79e-44	4.55e-39	(2021) Homologous Recombination as a Fundamental Genome Surveillance Mechanism during DNA Replication.
PMID	26	8.18e-44	4.66e-39	(2018) Methodologies for Improving HDR Efficiency.
PMID	27	9.94e-44	5.59e-39	(2022) Telomeric replication stress: the beginning and the end for alternative lengthening of telomeres cancers.
PMID	25	1.25e-43	6.94e-39	(2021) Impact of DNA damage repair defects and aggressive variant features on response to carboplatin-based chemotherapy in metastatic castration-resistant prostate cancer.
Process	29	1.03e-41	7.37e-39	DNA integrity checkpoint signaling
PMID	24	1.72e-43	9.45e-39	(2009) Fanconi anemia proteins and endogenous stresses.
Keyword	81	4.31e-41	9.65e-39	Nucleus
Process	28	1.75e-41	1.19e-38	Telomere maintenance
PMID	26	2.68e-43	1.45e-38	(2020) Fanconi anemia and the underlying causes of genomic instability.
PMID	24	2.97e-43	1.59e-38	(2022) Regulation of Replication Stress in Alternative Lengthening of Telomeres by Fanconi Anaemia Protein.
RCTM	37	2.18e-40	1.72e-38	Transcriptional Regulation by TP53
PMID	29	4.73e-43	2.5e-38	(2019) Functional Analysis of the Replication Fork Proteome Identifies BET Proteins as PCNA Regulators.
PMID	24	5.05e-43	2.64e-38	(2017) FANCD2 and DNA Damage.
PMID	24	5.05e-43	2.64e-38	(2016) The Simple Chordate Ciona intestinalis Has a Reduced Complement of Genes Associated with Fanconi Anemia.
Process	47	4.09e-41	2.68e-38	Cell cycle process
PMID	26	8.36e-43	4.26e-38	(2019) Total copy number variation as a prognostic factor in adult astrocytoma subtypes.
HPO	25	4.08e-42	4.98e-38	Abnormality of chromosome stability
Process	39	8.65e-41	5.22e-38	Regulation of cell cycle phase transition
PMID	25	1.79e-42	9.009999999999999e-38	(2013) Advances in understanding the complex mechanisms of DNA interstrand cross-link repair.
PMID	25	1.79e-42	9.009999999999999e-38	(2017) S-phase checkpoint regulations that preserve replication and chromosome integrity upon dNTP depletion.
PMID	25	2.71e-42	1.34e-37	(2019) The BRCA2 mutation status shapes the immune phenotype of prostate cancer.
PMID	25	2.71e-42	1.34e-37	(2012) Central Role of Ubiquitination in Genome Maintenance: DNA Replication and Damage Repair.
PMID	24	3.7699999999999996e-42	1.82e-37	(2010) A histone-fold complex and FANCM form a conserved DNA-remodeling complex to maintain genome stability.
PMID	24	3.7699999999999996e-42	1.82e-37	(2020) Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets.
PMID	23	4.49e-42	2.12e-37	(2019) Mapping global and local coevolution across 600 species to identify novel homologous recombination repair genes.
PMID	23	4.49e-42	2.12e-37	(2020) Common fragile sites: protection and repair.
PMID	26	4.99e-42	2.3e-37	(2017) The essential kinase ATR: ensuring faithful duplication of a challenging genome.
PMID	28	6.33e-42	2.8900000000000003e-37	(2018) Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place.
PMID	23	7.9e-42	3.5700000000000003e-37	(2018) The Zebrafish as an Emerging Model to Study DNA Damage in Aging, Cancer and Other Diseases.
PMID	31	8.769999999999999e-42	3.9300000000000005e-37	(2014) A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapy.
PMID	25	9.07e-42	4.02e-37	(2019) Phosphorylation of FANCD2 Inhibits the FANCD2FANCI Complex and Suppresses the Fanconi Anemia Pathway in the Absence of DNA Damage.
Function	33	1.01e-40	5.01e-37	Catalytic activity, acting on DNA
PMID	25	1.34e-41	5.870000000000001e-37	(2009) Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights.
NetworkNeighborAL	21	1.32e-39	6.71e-37	Resolution of D-loop Structures through Holliday Junction Intermediates, and DNA translocase activity
Process	40	1.16e-38	6.29e-36	Regulation of DNA metabolic process
Process	47	2.74e-38	1.38e-35	Chromosome organization
Process	33	5.44e-38	2.66e-35	Negative regulation of cell cycle process
Process	28	5.99e-38	2.76e-35	Signal transduction in response to DNA damage
DISEASES	21	8.64e-39	3.9700000000000004e-35	Fanconi anemia
Process	22	2.02e-37	9.070000000000001e-35	Interstrand cross-link repair
Function	63	3.98e-38	9.820000000000001e-35	DNA binding
Process	26	5.85e-37	2.55e-34	DNA damage checkpoint signaling
HPO	21	8.27e-38	5.05e-34	Duodenal stenosis
HPO	20	3.6500000000000003e-37	1.11e-33	Pyridoxine-responsive sideroblastic anemia
COMPARTMENTS	78	4.04e-36	1.33e-33	Protein-containing complex
Process	23	5.42e-36	2.18e-33	Homologous recombination
Keyword	19	1.5e-35	2.52e-33	Fanconi anemia
HPO	20	1.2e-36	2.92e-33	Aplasia/Hypoplasia of the uvula
HPO	20	1.2e-36	2.92e-33	Absent testis
Component	85	2.07e-35	5.2900000000000004e-33	Nucleus
Process	41	1.76e-35	6.89e-33	Regulation of cell cycle process
Process	22	2.6800000000000003e-35	1.03e-32	DNA-templated DNA replication maintenance of fidelity
HPO	20	1.75e-35	3.06e-32	Abnormal preputium morphology
HPO	20	1.75e-35	3.06e-32	Clubbing of toes
Component	76	3.83e-34	8.71e-32	Intracellular non-membrane-bounded organelle
Process	30	2.9e-34	1.06e-31	Meiotic cell cycle
HPO	20	1.85e-34	2.26e-31	Almond-shaped palpebral fissure
Component	47	7.880000000000001e-33	1.47e-30	Nuclear protein-containing complex
HPO	21	2.39e-33	2.43e-30	Hypoplasia of the ulna
COMPARTMENTS	45	1.52e-32	3.18e-30	Nucleoplasm
Process	20	1.01e-32	3.5e-30	Replication fork processing
HPO	22	4.2400000000000004e-33	3.98e-30	Forearm undergrowth
HPO	21	1.52e-32	1.2500000000000001e-29	Multiple cafe-au-lait spots
HPO	20	1.44e-32	1.2500000000000001e-29	Obsolete Abnormality of the ulna
HPO	25	1.67e-32	1.2500000000000001e-29	Cafe-au-lait spot
HPO	27	2.4500000000000002e-32	1.57e-29	Hypermelanotic macule
HPO	20	4.05e-32	2.4700000000000002e-29	Bicornuate uterus
HPO	22	5.16e-32	3e-29	Aplasia/Hypoplasia of the radius
WikiPathways	20	2.76e-31	7.19e-29	DNA IR-double strand breaks and cellular response via ATM
HPO	20	2.03e-31	1.03e-28	Arteriovenous malformation
HPO	23	2.48e-31	1.21e-28	Abnormality of the choanae
HPO	20	3.74e-31	1.75e-28	Meckel diverticulum
HPO	20	5.03e-31	2.27e-28	Abnormal carotid artery morphology
HPO	23	6.26e-31	2.73e-28	Anal atresia
Process	43	1.1299999999999999e-30	3.84e-28	Regulation of cell cycle
Function	23	3.6100000000000003e-31	5.93e-28	ATP-dependent activity, acting on DNA
HPO	22	2.04e-30	7.76e-28	Myelodysplasia
HPO	22	2.48e-30	9.17e-28	Recurrent urinary tract infections
HPO	20	3.59e-30	1.2900000000000002e-27	Triphalangeal thumb
HPO	22	3.66e-30	1.2900000000000002e-27	Choanal atresia
HPO	20	4.68e-30	1.59e-27	Tracheoesophageal fistula
Process	22	6.49e-30	2.1600000000000003e-27	DNA conformation change
HPO	20	1.3e-29	4.3e-27	Hydroureter
HPO	26	1.5999999999999999e-29	5.130000000000001e-27	Weight loss
Process	21	1.9200000000000002e-29	6.270000000000001e-27	DNA duplex unwinding
HPO	22	2.77e-29	8.68e-27	Abnormal spermatogenesis
HPO	28	3.31e-29	1.01e-26	Hyperpigmentation of the skin
HPO	21	4.33e-29	1.2900000000000001e-26	Azoospermia
HPO	21	5.29e-29	1.54e-26	Spina bifida
HPO	26	7.07e-29	2.01e-26	Hematological neoplasm
HPO	21	7.82e-29	2.1700000000000002e-26	Aplasia/Hypoplasia of the iris
COMPARTMENTS	15	1.25e-28	2.22e-26	Fanconi anaemia nuclear complex
Process	23	1.92e-28	5.899999999999999e-26	Negative regulation of DNA metabolic process
HPO	21	2.42e-28	6.42e-26	Hypopigmented skin patches
Process	22	3.32e-28	9.999999999999999e-26	Mitotic cell cycle checkpoint signaling
HPO	31	5.08e-28	1.29e-25	Intrauterine growth retardation
Function	22	1.08e-28	1.33e-25	Single-stranded DNA binding
HPO	20	6.07e-28	1.51e-25	External ear malformation
Function	65	2.41e-28	2.38e-25	Nucleic acid binding
HPO	20	1.3500000000000001e-27	3.24e-25	Leukopenia
Component	72	2.0800000000000004e-27	3.54e-25	Protein-containing complex
HPO	21	2.71e-27	6.24e-25	Facial asymmetry
COMPARTMENTS	85	3.84e-27	6.31e-25	Intracellular organelle
Process	18	2.1900000000000003e-27	6.48e-25	Reciprocal meiotic recombination
Keyword	19	5.380000000000001e-27	7.23e-25	DNA recombination
HPO	22	4.0400000000000005e-27	9.13e-25	Abnormal localization of kidney
HPO	23	4.94e-27	1.0999999999999998e-24	Abnormal morphology of the radius
NetworkNeighborAL	15	2.5800000000000004e-27	1.18e-24	Fanconi anaemia nuclear complex, and Fanconi anemia complementation group I
COMPARTMENTS	14	1.74e-26	2.6699999999999998e-24	Mre11 complex
HPO	22	1.3600000000000002e-26	2.91e-24	Abnormal esophagus morphology
RCTM	16	3.9500000000000003e-26	3.01e-24	Activation of ATR in response to replication stress
Process	19	1.25e-26	3.57e-24	Mitotic DNA damage checkpoint signaling
NetworkNeighborAL	14	9.05e-27	3.76e-24	Fanconi anaemia nuclear complex
HPO	23	2.52e-26	5.3e-24	Functional abnormality of male internal genitalia
Process	23	2.52e-26	7.05e-24	Meiotic cell cycle process
HPO	21	3.62e-26	7.35e-24	Decreased fertility in males
HPO	22	3.77e-26	7.55e-24	Sloping forehead
HPO	22	4.27e-26	8.27e-24	Abnormal uvula morphology
WikiPathways	18	5.56e-26	1.0899999999999999e-23	DNA damage response
WikiPathways	18	8.710000000000001e-26	1.36e-23	miRNA regulation of DNA damage response
HPO	20	7.850000000000001e-26	1.47e-23	Abnormality of enteric ganglion morphology
HPO	20	7.850000000000001e-26	1.47e-23	Aganglionic megacolon
HPO	20	1.2599999999999999e-25	2.2199999999999997e-23	Abnormal aortic valve morphology
HPO	21	1.44e-25	2.51e-23	Clubbing
HPO	22	1.8e-25	3.09e-23	Hypopigmentation of the skin
HPO	21	2.14e-25	3.58e-23	Aplasia/Hypoplasia of the testes
Process	21	1.44e-25	3.89e-23	Response to ionizing radiation
HPO	15	2.65e-25	4.37e-23	Chromosome breakage
HPO	23	4.28e-25	6.969999999999999e-23	Hip dislocation
HPO	25	4.67e-25	7.489999999999999e-23	Clinodactyly of the 5th finger
HPO	25	5.0499999999999995e-25	8.000000000000001e-23	Deviation of the 5th finger
HPO	20	6.46e-25	1.01e-22	Short palpebral fissure
HPO	20	7.44e-25	1.15e-22	Tetralogy of Fallot
RCTM	39	1.58e-24	1.16e-22	Generic Transcription Pathway
HPO	20	8.57e-25	1.29e-22	Abnormal ureter morphology
HPO	22	9.51e-25	1.4100000000000001e-22	Anemia (phenotype)
HPO	21	9.7e-25	1.43e-22	Dolichocephaly
HPO	20	1.2999999999999998e-24	1.87e-22	Abnormal tracheal morphology
Component	13	1.24e-24	1.96e-22	Fanconi anaemia nuclear complex
Process	20	7.44e-25	1.98e-22	Meiosis I cell cycle process
Process	29	8.74e-25	2.28e-22	Regulation of mitotic cell cycle
HPO	24	1.7599999999999998e-24	2.47e-22	Abnormality of globe size
Process	25	1.18e-24	3.04e-22	Positive regulation of DNA metabolic process
HPO	20	3.32e-24	4.5100000000000005e-22	Oligohydramnios
HPO	23	4.02e-24	5.34e-22	Microphthalmia
HPO	22	5.41e-24	7.03e-22	Toe syndactyly
HPO	28	5.65e-24	7.25e-22	Abnormal cellular physiology
HPO	27	6.15e-24	7.810000000000001e-22	Abnormality of the female genitalia
Component	23	6.24e-24	9.12e-22	Nuclear chromosome
HPO	24	1.1799999999999999e-23	1.4800000000000002e-21	Abnormal hip joint morphology
HPO	22	1.29e-23	1.6e-21	Proptosis
HPO	25	1.92e-23	2.3400000000000003e-21	Hypogonadism
HPO	24	2.67e-23	3.23e-21	Joint dislocation
HPO	25	4.24e-23	4.9900000000000006e-21	Abnormal morphology of female internal genitalia
HPO	23	4.2099999999999996e-23	4.9900000000000006e-21	Abnormal size of the palpebral fissures
HPO	20	4.8499999999999996e-23	5.53e-21	Abnormality of bone marrow cell morphology
Process	19	2.2799999999999997e-23	5.6900000000000005e-21	Meiosis I
RCTM	14	1.02e-22	7.04e-21	Telomere C-strand (Lagging Strand) Synthesis
HPO	23	7.29e-23	8.240000000000001e-21	Anorectal anomaly
RCTM	17	1.29e-22	8.670000000000001e-21	Meiosis
HPO	25	9.13e-23	1.02e-20	Abnormal leukocyte count
HPO	23	9.919999999999999e-23	1.1e-20	Abnormal tracheobronchial morphology
COMPARTMENTS	24	8.939999999999999e-23	1.14e-20	Nuclear chromosome
RCTM	15	1.92e-22	1.25e-20	Extension of Telomeres
HPO	19	1.2500000000000001e-22	1.37e-20	Abnormality of multiple cell lineages in the bone marrow
Process	24	6.77e-23	1.66e-20	Regulation of response to DNA damage stimulus
NetworkNeighborAL	12	4.5599999999999994e-23	1.74e-20	Resolution of recombination intermediates, and Response to intra-S DNA damage checkpoint signaling
HPO	31	1.69e-22	1.83e-20	Neoplasm by anatomical site
HPO	22	1.81e-22	1.94e-20	Decreased fertility
RCTM	18	3.96e-22	2.51e-20	Chromosome Maintenance
HPO	23	2.43e-22	2.58e-20	Hypospadias
Component	19	2.04e-22	2.78e-20	Chromosome, telomeric region
NetworkNeighborAL	12	8.749999999999999e-23	3.08e-20	ATR signaling, and Mitotic DNA replication checkpoint signaling
HPO	20	3.0500000000000003e-22	3.18e-20	Finger syndactyly
Process	20	1.46e-22	3.52e-20	Meiotic nuclear division
HPO	22	3.48e-22	3.6e-20	Abnormality of femur morphology
COMPARTMENTS	15	3.16e-22	3.82e-20	DNA repair complex
RCTM	15	6.45e-22	3.98e-20	Meiotic recombination
HPO	25	3.93e-22	4.03e-20	Abnormal internal genitalia
Function	70	6.12e-23	4.31e-20	Heterocyclic compound binding
HPO	22	4.78e-22	4.86e-20	Ocular anterior segment dysgenesis
HPO	22	4.78e-22	4.86e-20	Abnormality of the ureter
HPO	21	6.22e-22	6.06e-20	Abnormality of the autonomic nervous system
Function	70	1.32e-22	8.13e-20	Organic cyclic compound binding
HPO	26	1.0100000000000002e-21	9.46e-20	Abnormal hip bone morphology
Function	16	1.88e-22	1.03e-19	Damaged DNA binding
HPO	25	1.3900000000000001e-21	1.28e-19	Reduced bone mineral density
Process	16	6.12e-22	1.45e-19	Cellular response to ionizing radiation
Process	29	6.31e-22	1.48e-19	Mitotic cell cycle
HPO	21	2.83e-21	2.57e-19	Astigmatism
Process	55	1.2500000000000001e-21	2.89e-19	Organelle organization
HPO	22	3.89e-21	3.52e-19	Renal insufficiency
HPO	20	5.33e-21	4.78e-19	Abnormal ventriculoarterial connection
Process	27	2.45e-21	5.57e-19	Mitotic cell cycle process
Keyword	43	6.3900000000000004e-21	7.16e-19	DNA-binding
RCTM	16	1.32e-20	7.53e-19	Telomere Maintenance
HPO	21	1.34e-20	1.14e-18	Upslanted palpebral fissure
HPO	23	1.39e-20	1.18e-18	Syndactyly
HPO	22	1.54e-20	1.29e-18	Thrombocytopenia
Process	25	7.33e-21	1.64e-18	Response to radiation
COMPARTMENTS	15	1.46e-20	1.68e-18	Chromosome, telomeric region
HPO	28	2.83e-20	2.35e-18	Micrognathia
HPO	20	2.89e-20	2.38e-18	Umbilical hernia
HPO	22	2.96e-20	2.41e-18	Aplasia/Hypoplasia of fingers
HPO	28	2.94e-20	2.41e-18	Aplasia/Hypoplasia of the mandible
HPO	21	3.21e-20	2.6e-18	Cranial nerve paralysis
HPO	29	3.97e-20	3.17e-18	Localized skin lesion
Process	19	1.48e-20	3.28e-18	Cellular response to radiation
HPO	22	4.92e-20	3.85e-18	Abnormal platelet count
HPO	20	5.04e-20	3.91e-18	Abnormal umbilicus morphology
HPO	28	5.21e-20	4.03e-18	Abnormal long bone morphology
HPO	20	8.01e-20	6.11e-18	Hypertrophic cardiomyopathy
HPO	22	8.07e-20	6.11e-18	Abnormal thumb morphology
WikiPathways	13	4.77e-20	6.21e-18	ATM signaling pathway
HPO	20	1.17e-19	8.81e-18	Patent ductus arteriosus
Process	22	4.92e-20	1.07e-17	Nuclear division
Process	15	5.12e-20	1.1e-17	Protein monoubiquitination
HPO	22	1.66e-19	1.24e-17	Abnormality of the peripheral nervous system
HPO	22	1.87e-19	1.39e-17	Hydrocephalus
HPO	16	1.94e-19	1.43e-17	Aplasia/Hypoplasia of the thumb
HPO	25	2.4e-19	1.75e-17	Abnormal cellular immune system morphology
HPO	27	2.52e-19	1.82e-17	Abnormal lower limb bone morphology
Process	11	9.52e-20	2.02e-17	Mitotic intra-S DNA damage checkpoint signaling
Process	17	1.04e-19	2.17e-17	Regulation of DNA replication
Function	26	5e-20	2.46e-17	ATP-dependent activity
HPO	27	3.81e-19	2.7e-17	Abnormality of reproductive system physiology
HPO	21	3.81e-19	2.7e-17	Pes planus
HPO	20	4.29e-19	3.01e-17	Renal hypoplasia/aplasia
COMPARTMENTS	12	3.32e-19	3.48e-17	Nuclear replication fork
Process	16	1.7e-19	3.51e-17	Regulation of cell cycle G2/M phase transition
HPO	21	5.53e-19	3.84e-17	Abnormality of the hypothalamus-pituitary axis
HPO	33	5.74e-19	3.96e-17	Short stature
HPO	21	6.65e-19	4.56e-17	Abnormality of the curvature of the cornea
HPO	34	7.12e-19	4.86e-17	Abnormality of body height
Component	22	5.83e-19	7.46e-17	Chromosomal region
HPO	34	1.18e-18	7.88e-17	Decreased body weight
HPO	25	1.37e-18	9.08e-17	Abnormality of lower limb joint
HPO	21	1.36e-18	9.08e-17	Frontal bossing
HPO	25	1.37e-18	9.08e-17	Abnormal bone ossification
HPO	21	1.44e-18	9.48e-17	Abnormal shape of the frontal region
RCTM	38	1.77e-18	9.86e-17	Disease
Keyword	15	1.11e-18	1.06e-16	DNA replication
Process	13	5.74e-19	1.15e-16	Mitotic G2/M transition checkpoint
COMPARTMENTS	22	1.39e-18	1.39e-16	Nuclear body
HPO	26	2.36e-18	1.53e-16	Abnormal bone structure
Process	10	7.69e-19	1.53e-16	T-circle formation
HPO	24	2.71e-18	1.75e-16	Aplasia/hypoplasia involving bones of the upper limbs
HPO	20	2.74e-18	1.76e-16	Abnormal aortic morphology
HPO	30	2.88e-18	1.84e-16	Abnormality of the male genitalia
HPO	25	3.16e-18	2.01e-16	Aplasia/hypoplasia involving bones of the extremities
HPO	22	3.34e-18	2.11e-16	Abnormal systemic arterial morphology
Process	15	1.27e-18	2.43e-16	Regulation of G2/M transition of mitotic cell cycle
NetworkNeighborAL	10	7.69e-19	2.51e-16	BRCA1-C complex, and NIPBL role in DNA damage - Cornelia de Lange syndrome
HPO	25	4.49e-18	2.82e-16	Abnormality of toe
HPO	21	5.29e-18	3.3e-16	Atrial septal defect
HPO	30	6.09e-18	3.77e-16	Abnormal facial shape
HPO	25	6.84e-18	4.19e-16	Slanting of the palpebral fissure
HPO	12	8.45e-18	5.15e-16	Absent thumb
HPO	23	1.02e-17	6.18e-16	Aplasia/hypoplasia involving bones of the hand
HPO	26	1.02e-17	6.18e-16	Abnormality of the palpebral fissures
HPO	27	1.32e-17	7.88e-16	Abnormal calvaria morphology
HPO	25	1.34e-17	7.96e-16	Cleft palate
HPO	25	1.44e-17	8.48e-16	Cryptorchidism
HPO	23	2.21e-17	1.3e-15	Anemia
COMPARTMENTS	18	1.44e-17	1.39e-15	Chromosomal region
HPO	22	2.75e-17	1.61e-15	Abnormal uvea morphology
HPO	9	2.88e-17	1.67e-15	Chromosomal breakage induced by crosslinking agents
WikiPathways	9	1.52e-17	1.69e-15	ATR signaling
HPO	35	3.11e-17	1.8e-15	Growth delay
HPO	28	3.17e-17	1.82e-15	Abnormal hand morphology
Process	10	9.86e-18	1.84e-15	DNA replication checkpoint signaling
HPO	27	3.47e-17	1.99e-15	Abnormal testis morphology
HPO	25	4.65e-17	2.64e-15	Abnormality of the lower urinary tract
HPO	24	6.7e-17	3.77e-15	Abnormal penis morphology
HPO	29	7.34e-17	4.09e-15	Aplasia/hypoplasia involving the skeleton
HPO	30	8.56e-17	4.75e-15	Microcephaly
Process	20	2.9e-17	5.28e-15	Regulation of mitotic cell cycle phase transition
HPO	30	1.04e-16	5.72e-15	Decreased head circumference
DISEASES	13	6.66e-18	6.12e-15	Breast cancer
Process	10	3.47e-17	6.26e-15	Mitotic recombination
Process	10	3.47e-17	6.26e-15	DNA double-strand break processing
HPO	27	1.61e-16	8.79e-15	Morphological abnormality of the gastrointestinal tract
HPO	27	1.8e-16	9.8e-15	Abnormality of digestive system morphology
HPO	28	1.81e-16	9.83e-15	Abnormality of male external genitalia
Process	15	6.46e-17	1.14e-14	Regulation of DNA recombination
HPO	20	2.21e-16	1.18e-14	Congenital malformation of the great arteries
HPO	20	2.69e-16	1.42e-14	Abdominal wall defect
Process	18	1.13e-16	1.96e-14	Nucleic acid phosphodiester bond hydrolysis
Process	17	1.13e-16	1.96e-14	Regulation of DNA repair
Process	12	1.28e-16	2.17e-14	Regulation of DNA-templated DNA replication
HPO	12	4.38e-16	2.29e-14	Neoplasm of the breast
HPO	29	4.37e-16	2.29e-14	Abnormal facial skeleton morphology
HPO	25	4.46e-16	2.3e-14	Recurrent infections
HPO	21	4.91e-16	2.53e-14	Epicanthus
HPO	28	5.4e-16	2.77e-14	Abnormality of the curvature of the vertebral column
HPO	32	5.76e-16	2.94e-14	Abnormality of the genital system
HPO	13	5.83e-16	2.97e-14	Short thumb
HPO	21	6.33e-16	3.2e-14	Cardiomyopathy
Process	34	2.19e-16	3.7e-14	Intracellular signal transduction
HPO	27	8.33e-16	4.2e-14	Abnormal joint morphology
Keyword	24	5.23e-16	4.39e-14	Cell cycle
HPO	32	9.77e-16	4.88e-14	Abnormality of the gastrointestinal tract
HPO	25	1.01e-15	5.05e-14	Unusual infection
HPO	24	1.07e-15	5.31e-14	Abnormal intestine morphology
WikiPathways	11	5.99e-16	5.85e-14	ATM signaling in development and disease 
HPO	31	1.24e-15	6.11e-14	Abnormality of connective tissue
HPO	31	1.41e-15	6.9e-14	Aplasia/Hypoplasia of the cerebrum
HPO	28	1.61e-15	7.84e-14	Abnormal pinna morphology
Process	10	7.13e-16	1.16e-13	Chromosome separation
HPO	22	2.68e-15	1.29e-13	Abnormal cardiac septum morphology
COMPARTMENTS	21	1.63e-15	1.5e-13	Chromatin
HPO	23	3.45e-15	1.65e-13	High palate
HPO	11	3.49e-15	1.66e-13	Bone marrow hypocellularity
HPO	11	3.49e-15	1.66e-13	Breast carcinoma
WikiPathways	12	2.41e-15	1.97e-13	Nucleotide excision repair in xeroderma pigmentosum 
WikiPathways	15	2.27e-15	1.97e-13	Primary ovarian insufficiency
HPO	23	4.33e-15	2.04e-13	Cataract
Process	33	1.3e-15	2.11e-13	Reproductive process
Process	13	1.4e-15	2.24e-13	Meiotic chromosome segregation
HPO	26	5.02e-15	2.36e-13	Abnormality of refraction
Component	12	2.41e-15	2.39e-13	Site of double-strand break
Component	13	2.24e-15	2.39e-13	Site of DNA damage
Process	15	1.64e-15	2.57e-13	Negative regulation of mitotic cell cycle phase transition
HPO	27	5.55e-15	2.59e-13	Abnormality of finger
HPO	26	8.37e-15	3.88e-13	Scoliosis
TISSUES	17	1.75e-16	4.24e-13	Pronephros
HPO	28	1.07e-14	4.95e-13	Abnormality of the upper urinary tract
HPO	23	1.14e-14	5.25e-13	Abnormal cornea morphology
Component	12	6.35e-15	5.9e-13	Condensed nuclear chromosome
HPO	29	1.63e-14	7.47e-13	Abnormal ocular adnexa morphology
HPO	33	1.73e-14	7.92e-13	Abnormality of skin morphology
HPO	35	1.92e-14	8.72e-13	Abnormality of the skin
Process	10	7.11e-15	1.09e-12	Negative regulation of telomere maintenance
WikiPathways	8	1.61e-14	1.14e-12	Homologous recombination
Process	58	9.4e-15	1.43e-12	Cellular component organization
HPO	29	3.24e-14	1.46e-12	Abnormality of the vertebral column
HPO	27	3.38e-14	1.52e-12	Abnormal eyelid morphology
Function	11	3.49e-15	1.57e-12	Deoxyribonuclease activity
HPO	31	3.76e-14	1.68e-12	Abnormality of the nose
HPO	37	3.75e-14	1.68e-12	Growth abnormality
Process	17	1.12e-14	1.69e-12	Chromosome segregation
HPO	27	4.22e-14	1.87e-12	Abnormality of the abdominal organs
DISEASES	11	4.18e-15	1.92e-12	Ovarian cancer
HPO	27	4.41e-14	1.95e-12	Abnormality of the endocrine system
DISEASES	13	4.93e-15	2.06e-12	Ovarian disease
HPO	22	5e-14	2.2e-12	Hyperreflexia
HPO	21	5.08e-14	2.23e-12	Abnormal morphology of the great vessels
HPO	27	5.14e-14	2.25e-12	Abnormality of the kidney
Keyword	13	3.03e-14	2.26e-12	Nuclease
HPO	25	6.53e-14	2.84e-12	Strabismus
HPO	12	6.85e-14	2.98e-12	Pancytopenia
NetworkNeighborAL	11	9.79e-15	2.99e-12	DNA replication, and Regulation of DNA-directed DNA polymerase activity
Keyword	19	4.8e-14	3.22e-12	Chromosome
Process	8	2.52e-14	3.77e-12	Telomere maintenance via recombination
HPO	24	1.11e-13	4.82e-12	Abnormal renal morphology
HPO	25	1.13e-13	4.88e-12	Abnormality of the forehead
HPO	28	1.15e-13	4.92e-12	Abnormality of blood and blood-forming tissues
RCTM	9	1.01e-13	5.49e-12	DNA strand elongation
HPO	25	1.43e-13	6.06e-12	Nystagmus
COMPARTMENTS	7	7.03e-14	6.22e-12	BRCA1-C complex
Function	11	1.58e-14	6.5e-12	DNA helicase activity
HPO	23	1.56e-13	6.57e-12	Abnormal cerebral ventricle morphology
HPO	25	1.68e-13	7.08e-12	Abnormal involuntary eye movements
HPO	21	1.86e-13	7.81e-12	Ventriculomegaly
HPO	29	2e-13	8.37e-12	Abnormality of immune system physiology
Function	15	2.25e-14	8.53e-12	Nuclease activity
HPO	30	2.15e-13	8.95e-12	Abnormality of limb bone morphology
Component	16	1.01e-13	8.95e-12	Condensed chromosome
Component	24	1.01e-13	8.95e-12	Nuclear body
HPO	28	2.45e-13	1.01e-11	Abnormal foot morphology
COMPARTMENTS	7	1.31e-13	1.12e-11	DNA replication factor A complex
Process	12	7.63e-14	1.12e-11	Regulation of telomere maintenance
RCTM	8	2.4e-13	1.27e-11	Lagging Strand Synthesis
Process	27	9.77e-14	1.42e-11	Response to abiotic stimulus
Process	8	1.22e-13	1.75e-11	Resolution of meiotic recombination intermediates
COMPARTMENTS	8	2.4e-13	1.97e-11	DNA recombinase mediator complex
HPO	30	4.81e-13	1.98e-11	Abnormality of the lower limb
NetworkNeighborAL	7	7.03e-14	2.01e-11	Fanconi anaemia nuclear complex
NetworkNeighborAL	7	7.03e-14	2.01e-11	RecQ family helicase-topoisomerase III complex, and RQC domain
RCTM	10	3.99e-13	2.07e-11	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
HPO	21	5.26e-13	2.16e-11	Ptosis
HPO	21	5.73e-13	2.35e-11	Hypertelorism
InterPro	26	3.31e-15	2.37e-11	P-loop containing nucleoside triphosphate hydrolase
DISEASES	7	7.03e-14	2.69e-11	Hereditary breast ovarian cancer syndrome
HPO	36	6.95e-13	2.84e-11	Abnormality of the integument
RCTM	9	7.01e-13	3.48e-11	Dual Incision in GG-NER
Process	10	2.52e-13	3.6e-11	Nucleotide-excision repair
WikiPathways	8	6.03e-13	3.92e-11	DNA mismatch repair
WikiPathways	7	6.43e-13	3.92e-11	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome
HPO	23	1e-12	4.04e-11	Abnormality of globe location
HPO	32	1.01e-12	4.08e-11	Abnormal cerebral morphology
COMPARTMENTS	11	5.48e-13	4.2e-11	Site of DNA damage
HPO	38	1.07e-12	4.28e-11	Abnormal skeletal morphology
HPO	24	1.08e-12	4.33e-11	Abnormality of the urinary system physiology
HPO	25	1.26e-12	5.02e-11	Abnormal palate morphology
COMPARTMENTS	10	7.13e-13	5.3e-11	Site of double-strand break
Function	9	1.62e-13	5.69e-11	Endodeoxyribonuclease activity
Function	8	1.72e-13	5.69e-11	ATP-dependent DNA damage sensor activity
RCTM	8	1.37e-12	6.67e-11	Polymerase switching on the C-strand of the telomere
KEGG	8	6.03e-13	6.75e-11	Mismatch repair
WikiPathways	9	1.23e-12	6.84e-11	Nucleotide excision repair
WikiPathways	9	1.23e-12	6.84e-11	Integrated cancer pathway
Process	15	4.95e-13	6.93e-11	Regulation of chromosome organization
HPO	35	1.78e-12	7.04e-11	Abnormal axial skeleton morphology
DISEASES	14	2.24e-13	7.92e-11	Female reproductive system disease
Component	9	1.02e-12	8.04e-11	DNA repair complex
Process	7	6.43e-13	8.93e-11	Telomeric loop disassembly
HPO	22	2.32e-12	9.1e-11	Abnormality of prenatal development or birth
HPO	25	2.43e-12	9.5e-11	Abnormal respiratory system morphology
Function	9	3.12e-13	9.63e-11	Telomeric DNA binding
Function	30	3.73e-13	1.08e-10	ATP binding
HPO	23	3.64e-12	1.41e-10	Abnormality of the liver
Keyword	28	2.39e-12	1.46e-10	ATP-binding
KEGG	9	1.75e-12	1.47e-10	Nucleotide excision repair
RCTM	8	3.65e-12	1.74e-10	Recognition of DNA damage by PCNA-containing replication complex
HPO	6	4.76e-12	1.84e-10	Primary peritoneal carcinoma
RCTM	9	3.99e-12	1.86e-10	Nonhomologous End-Joining (NHEJ)
HPO	30	5.22e-12	2.01e-10	Intellectual disability
Process	12	1.49e-12	2.04e-10	Regulation of double-strand break repair
COMPARTMENTS	8	2.89e-12	2.08e-10	Replisome
Keyword	10	3.8e-12	2.13e-10	Endonuclease
Component	8	2.89e-12	2.19e-10	Nuclear replication fork
RCTM	7	4.87e-12	2.22e-10	Translesion synthesis by REV1
HPO	30	6.73e-12	2.57e-10	Abnormality of the vasculature
Process	10	2.07e-12	2.82e-10	Regulation of double-strand break repair via homologous recombination
Process	14	2.14e-12	2.9e-10	Nuclear chromosome segregation
COMPARTMENTS	10	4.27e-12	2.98e-10	PML body
RCTM	7	6.85e-12	3.07e-10	Translesion synthesis by POLK
RCTM	7	6.85e-12	3.07e-10	Translesion synthesis by POLI
COMPARTMENTS	6	4.76e-12	3.22e-10	Rad51B-Rad51C-Rad51D-XRCC2 complex
DISEASES	32	9.99e-13	3.28e-10	Autosomal recessive disease
Component	6	4.76e-12	3.48e-10	BRCA1-C complex
HPO	7	9.48e-12	3.62e-10	Abnormal fallopian tube morphology
HPO	33	1.01e-11	3.82e-10	Abnormal eye morphology
Function	16	1.63e-12	3.83e-10	ATP hydrolysis activity
HPO	32	1.09e-11	4.12e-10	Abnormal skull morphology
HPO	24	1.14e-11	4.32e-10	Abnormal reflex
InterPro	7	1.31e-13	4.72e-10	DNA recombination and repair protein Rad51-like, C-terminal
InterPro	7	1.31e-13	4.72e-10	DNA recombination and repair protein RecA-like, ATP-binding domain
Process	8	3.65e-12	4.89e-10	Telomere maintenance via telomere lengthening
RCTM	7	1.29e-11	5.57e-10	Processive synthesis on the C-strand of the telomere
RCTM	7	1.29e-11	5.57e-10	Translesion Synthesis by POLH
HPO	28	1.49e-11	5.63e-10	Abnormality of eye movement
WikiPathways	10	1.15e-11	5.63e-10	Retinoblastoma gene in cancer
NetworkNeighborAL	8	2.27e-12	5.78e-10	Polymerase switching, and Epsilon DNA polymerase complex
COMPARTMENTS	6	8.8e-12	5.79e-10	Slx1-Slx4 complex
Process	6	4.76e-12	6.32e-10	Resolution of recombination intermediates
HPO	9	1.7e-11	6.37e-10	Melanoma
HPO	34	1.75e-11	6.55e-10	Abnormality of brain morphology
HPO	32	1.8e-11	6.71e-10	Abnormality of the mouth
Process	8	5.7e-12	7.51e-10	Negative regulation of DNA replication
HPO	36	2.08e-11	7.74e-10	Abnormal nervous system morphology
RCTM	9	1.94e-11	8.04e-10	TP53 Regulates Transcription of DNA Repair Genes
Function	8	3.65e-12	8.18e-10	DNA secondary structure binding
DISEASES	39	2.89e-12	8.19e-10	Autosomal genetic disease
KEGG	8	1.3e-11	8.7e-10	DNA replication
HPO	35	2.35e-11	8.71e-10	Morphological central nervous system abnormality
HPO	32	2.52e-11	9.31e-10	Abnormality of limbs
Function	12	4.4e-12	9.42e-10	Helicase activity
RCTM	7	2.31e-11	9.42e-10	PCNA-Dependent Long Patch Base Excision Repair
Process	9	7.34e-12	9.59e-10	Response to gamma radiation
Process	10	7.51e-12	9.74e-10	Negative regulation of response to DNA damage stimulus
DISEASES	21	3.99e-12	1.02e-09	Physical disorder
HPO	14	2.91e-11	1.07e-09	Short finger
HPO	31	2.92e-11	1.07e-09	Abnormal oral cavity morphology
HPO	31	3e-11	1.1e-09	Cognitive impairment
Process	8	8.69e-12	1.11e-09	Mitotic G2 DNA damage checkpoint signaling
Process	6	8.8e-12	1.11e-09	DNA strand resection involved in replication fork processing
HPO	29	3.08e-11	1.12e-09	Abnormality of the urinary system
RCTM	9	2.84e-11	1.14e-09	Dual incision in TC-NER
NetworkNeighborAL	6	4.76e-12	1.15e-09	BRCA1-C complex
NetworkNeighborAL	6	4.76e-12	1.15e-09	ATR signaling, and Meiotic DNA double-strand break processing involved in reciprocal meiotic recombination
NetworkNeighborAL	6	4.76e-12	1.15e-09	DNA recombination and repair protein Rad51-like, C-terminal, and Rad52 family
Process	50	9.55e-12	1.2e-09	Negative regulation of cellular process
HPO	24	3.57e-11	1.3e-09	Abnormal anterior eye segment morphology
HPO	33	4.08e-11	1.48e-09	Abnormality of the genitourinary system
Process	11	1.37e-11	1.71e-09	Regulation of DNA biosynthetic process
WikiPathways	8	3.84e-11	1.77e-09	DNA replication
Process	6	1.54e-11	1.9e-09	Double-strand break repair via synthesis-dependent strand annealing
Process	6	1.54e-11	1.9e-09	Negative regulation of telomere capping
RCTM	9	6.55e-11	2.55e-09	Base Excision Repair
RCTM	7	6.48e-11	2.55e-09	Gap-filling DNA repair synthesis and ligation in GG-NER
DISEASES	15	1.07e-11	2.59e-09	Reproductive system disease
Keyword	11	5.01e-11	2.59e-09	Helicase
Process	6	2.55e-11	3.1e-09	Replication fork protection
Process	6	2.55e-11	3.1e-09	Telomeric D-loop disassembly
RCTM	6	9.36e-11	3.5e-09	HDR through MMEJ (alt-NHEJ)
DISEASES	12	1.54e-11	3.54e-09	Reproductive organ cancer
Process	7	3.04e-11	3.64e-09	DNA unwinding involved in DNA replication
HPO	34	1.02e-10	3.67e-09	Abnormal eye physiology
Component	10	5.39e-11	3.68e-09	PML body
Process	9	3.64e-11	4.29e-09	Positive regulation of telomere maintenance
HPO	28	1.27e-10	4.56e-09	Abnormality of the respiratory system
COMPARTMENTS	9	7.33e-11	4.56e-09	Condensed nuclear chromosome
HPO	37	1.47e-10	5.26e-09	Abnormality of the eye
HPO	34	1.47e-10	5.26e-09	Abnormality of the cardiovascular system
HPO	33	1.52e-10	5.41e-09	Abnormality of higher mental function
COMPARTMENTS	6	9.36e-11	5.67e-09	Endodeoxyribonuclease complex
Process	7	5.08e-11	5.95e-09	Nuclear DNA replication
HPO	33	1.95e-10	6.92e-09	Neurodevelopmental abnormality
Process	45	6.29e-11	7.31e-09	Regulation of nucleobase-containing compound metabolic process
DISEASES	25	3.75e-11	8.21e-09	Syndrome
HPO	27	2.35e-10	8.31e-09	Global developmental delay
HPO	25	2.39e-10	8.44e-09	Hearing abnormality
Process	26	8.38e-11	9.6e-09	Regulation of response to stress
HPO	35	2.77e-10	9.73e-09	Abnormality of the face
RCTM	7	2.89e-10	1.02e-08	Termination of translesion DNA synthesis
WikiPathways	7	2.38e-10	1.03e-08	Gastric cancer network 2
Process	8	1.15e-10	1.31e-08	Regulation of cell cycle checkpoint
HPO	33	4.04e-10	1.41e-08	Abnormality of the digestive system
HPO	25	4.09e-10	1.43e-08	Abnormal ear physiology
DISEASES	40	7.27e-11	1.52e-08	Monogenic disease
RCTM	6	5e-10	1.73e-08	Removal of the Flap Intermediate from the C-strand
COMPARTMENTS	5	3.22e-10	1.9e-08	RecQ family helicase-topoisomerase III complex
COMPARTMENTS	5	3.22e-10	1.9e-08	ATR-ATRIP complex
HPO	38	5.8e-10	2.02e-08	Abnormality of the musculoskeletal system
HPO	36	5.86e-10	2.03e-08	Abnormality of the head
COMPARTMENTS	6	3.71e-10	2.08e-08	Nonhomologous end joining complex
Keyword	33	4.5e-10	2.16e-08	Ubl conjugation
HPO	6	6.65e-10	2.3e-08	Prostate cancer
SMART	7	3.04e-11	2.49e-08	Breast cancer carboxy-terminal domain
SMART	11	3.23e-11	2.49e-08	ATPases associated with a variety of cellular activities
HPO	24	7.52e-10	2.58e-08	Hearing impairment
HPO	31	7.63e-10	2.61e-08	Abnormality of metabolism/homeostasis
Process	7	2.38e-10	2.69e-08	Response to X-ray
Process	27	2.45e-10	2.75e-08	Negative regulation of nucleobase-containing compound metabolic process
COMPARTMENTS	5	5.88e-10	3.22e-08	Holliday junction resolvase complex
HPO	10	9.53e-10	3.25e-08	Leukemia
HPO	29	9.59e-10	3.26e-08	Abnormality of the ear
HPO	7	9.82e-10	3.33e-08	Hypoplasia of the radius
HPO	29	1.04e-09	3.52e-08	Neurodevelopmental delay
Function	10	2.35e-10	4e-08	Endonuclease activity
HPO	23	1.2e-09	4.06e-08	Abnormal heart morphology
Process	6	3.71e-10	4.1e-08	Replicative senescence
HPO	21	1.28e-09	4.31e-08	Visual impairment
Component	24	7.19e-10	4.75e-08	Chromatin
Process	9	4.89e-10	5.37e-08	DNA biosynthetic process
COMPARTMENTS	5	1.01e-09	5.38e-08	ERCC4-ERCC1 complex
COMPARTMENTS	5	1.01e-09	5.38e-08	Ctf18 RFC-like complex
TISSUES	21	4.45e-11	5.39e-08	Embryo
Component	5	1.01e-09	6.43e-08	DNA recombinase mediator complex
Component	5	1.01e-09	6.43e-08	Ctf18 RFC-like complex
NetworkNeighborAL	5	3.22e-10	6.7e-08	Response to intra-S DNA damage checkpoint signaling, and Crossover junction endodeoxyribonuclease activity
COMPARTMENTS	11	1.51e-09	7.74e-08	protein-DNA complex
RCTM	10	2.4e-09	7.82e-08	DNA Replication
Keyword	27	1.92e-09	8.07e-08	Isopeptide bond
WikiPathways	9	1.98e-09	8.12e-08	Androgen receptor network in prostate cancer
Process	8	7.94e-10	8.58e-08	Regulation of telomere maintenance via telomere lengthening
HPO	13	2.63e-09	8.79e-08	Abnormal breast morphology
KEGG	10	1.68e-09	9.39e-08	Cellular senescence
Function	5	5.88e-10	9.67e-08	Four-way junction helicase activity
HPO	7	3.16e-09	1.05e-07	Ectopic kidney
HPO	27	3.19e-09	1.06e-07	Abnormality of movement
InterPro	7	6.48e-11	1.16e-07	BRCT domain superfamily
HPO	6	3.55e-09	1.17e-07	Absent radius
HPO	12	3.54e-09	1.17e-07	Neoplasm by histology
NetworkNeighborAL	5	5.88e-10	1.17e-07	Checkpoint clamp complex
DISEASES	5	5.88e-10	1.18e-07	Bloom syndrome
Function	31	7.63e-10	1.21e-07	Nucleotide binding
Process	6	1.13e-09	1.21e-07	DNA strand elongation
Keyword	62	3.41e-09	1.35e-07	Phosphoprotein
NetworkNeighborAL	5	1.01e-09	1.92e-07	DNA replication factor C complex, and PCNA-p21 complex
HPO	7	5.98e-09	1.96e-07	Ovarian neoplasm
Process	7	2.09e-09	2.21e-07	Negative regulation of DNA recombination
HPO	38	7.58e-09	2.47e-07	Abnormality of the nervous system
HPO	36	8.1e-09	2.63e-07	Abnormal nervous system physiology
Process	51	3.51e-09	3.69e-07	Regulation of nitrogen compound metabolic process
Process	6	3.55e-09	3.71e-07	RNA-templated DNA biosynthetic process
Function	5	2.52e-09	3.77e-07	Flap endonuclease activity
HPO	9	1.22e-08	3.96e-07	Prematurely aged appearance
Process	29	4.62e-09	4.77e-07	Positive regulation of nucleobase-containing compound metabolic process
Process	13	5e-09	5.13e-07	Negative regulation of organelle organization
Process	6	5.31e-09	5.4e-07	Regulation of DNA damage checkpoint
HPO	4	2.19e-08	7.08e-07	Prolonged G2 phase of cell cycle
HPO	4	2.19e-08	7.08e-07	Deficient excision of UV-induced pyrimidine dimers in DNA
RCTM	7	2.24e-08	7.1e-07	Gap-filling DNA repair synthesis and ligation in TC-NER
Process	6	7.72e-09	7.81e-07	Cellular response to gamma radiation
Function	5	5.47e-09	7.93e-07	3-5 DNA helicase activity
InterPro	5	5.88e-10	8.45e-07	DNA recombination and repair protein, RecA-like
HPO	25	2.74e-08	8.79e-07	Abnormality of cardiovascular system morphology
Process	36	8.96e-09	9.01e-07	Positive regulation of nitrogen compound metabolic process
Process	6	9.24e-09	9.23e-07	Negative regulation of telomere maintenance via telomere lengthening
Process	51	1e-08	9.97e-07	Regulation of primary metabolic process
HPO	5	3.23e-08	1.03e-06	Abnormality of DNA repair
Process	5	1.07e-08	1.05e-06	Positive regulation of DNA-directed DNA polymerase activity
Function	5	7.72e-09	1.09e-06	Single-stranded telomeric DNA binding
COMPARTMENTS	4	2.19e-08	1.1e-06	BRCA1-B complex
COMPARTMENTS	4	2.19e-08	1.1e-06	Rad17 RFC-like complex
HPO	9	3.75e-08	1.19e-06	Neutropenia
Component	4	2.19e-08	1.32e-06	Rad51B-Rad51C-Rad51D-XRCC2 complex
Component	4	2.19e-08	1.32e-06	RecQ family helicase-topoisomerase III complex
Component	4	2.19e-08	1.32e-06	BRCA1-B complex
COMPARTMENTS	10	2.87e-08	1.37e-06	Condensed chromosome
HPO	8	5.37e-08	1.7e-06	Telangiectasia
HPO	13	5.52e-08	1.74e-06	Vascular skin abnormality
COMPARTMENTS	4	3.93e-08	1.81e-06	FANCM-MHF complex
COMPARTMENTS	4	3.93e-08	1.81e-06	Elg1 RFC-like complex
COMPARTMENTS	4	3.93e-08	1.81e-06	Checkpoint clamp complex
Keyword	6	4.9e-08	1.83e-06	Telomere
RCTM	4	6.53e-08	2.02e-06	Sensing of DNA Double Strand Breaks
Process	6	2.1e-08	2.04e-06	Negative regulation of DNA repair
Process	4	2.19e-08	2.12e-06	Response to intra-S DNA damage checkpoint signaling
Component	4	3.93e-08	2.18e-06	Checkpoint clamp complex
Component	4	3.93e-08	2.18e-06	DNA replication factor C complex
HPO	17	8.24e-08	2.57e-06	Generalized abnormality of skin
Process	9	2.72e-08	2.62e-06	Response to UV
InterPro	6	2.31e-09	2.76e-06	BRCT domain
COMPARTMENTS	4	6.53e-08	2.84e-06	DNA replication factor C complex
Process	5	3.23e-08	3.09e-06	Telomere capping
HPO	4	1.02e-07	3.19e-06	Anemic pallor
Component	4	6.53e-08	3.43e-06	FANCM-MHF complex
Process	16	3.96e-08	3.76e-06	Protein ubiquitination
WikiPathways	4	1.02e-07	4e-06	DDX1 as a regulatory component of the Drosha microprocessor
Process	37	4.55e-08	4.3e-06	Positive regulation of macromolecule metabolic process
DISEASES	17	2.61e-08	4.61e-06	Organ system cancer
Function	4	3.93e-08	4.73e-06	Y-form DNA binding
Function	48	3.98e-08	4.73e-06	Catalytic activity
Function	4	3.93e-08	4.73e-06	Crossover junction endodeoxyribonuclease activity
Process	7	5.18e-08	4.86e-06	Positive regulation of DNA biosynthetic process
Process	5	5.18e-08	4.86e-06	Negative regulation of double-strand break repair via homologous recombination
HPO	6	1.78e-07	5.53e-06	Neoplasm of the pancreas
WikiPathways	4	1.53e-07	5.69e-06	NIPBL role in DNA damage - Cornelia de Lange syndrome
Process	6	6.34e-08	5.89e-06	Double-strand break repair via nonhomologous end joining
Process	7	6.7e-08	6.18e-06	Chromosome organization involved in meiotic cell cycle
HPO	17	2.01e-07	6.22e-06	Mean corpuscular volume
Process	9	6.88e-08	6.31e-06	Positive regulation of response to DNA damage stimulus
DISEASES	4	3.93e-08	6.69e-06	Rothmund-Thomson syndrome
DISEASES	4	3.93e-08	6.69e-06	Nijmegen breakage syndrome
DISEASES	4	3.93e-08	6.69e-06	Werner syndrome
SMART	4	3.93e-08	7e-06	ERCC4 domain
SMART	8	3.38e-08	7e-06	Helicase superfamily c-terminal domain
SMART	8	2.56e-08	7e-06	DEAD-like helicases superfamily
Function	77	6.5e-08	7.12e-06	Binding
Process	5	7.96e-08	7.26e-06	Blastocyst growth
Process	51	8.1e-08	7.34e-06	Regulation of macromolecule metabolic process
HPO	6	2.67e-07	8.24e-06	Hypergonadotropic hypogonadism
Keyword	23	2.45e-07	8.68e-06	Hydrolase
HPO	9	2.84e-07	8.74e-06	Small for gestational age
Process	5	9.74e-08	8.78e-06	Telomere maintenance via telomerase
Function	29	8.62e-08	8.86e-06	Hydrolase activity
Process	4	1.02e-07	9.17e-06	DNA double-strand break processing involved in repair via single-strand annealing
Process	4	1.02e-07	9.17e-06	Regulation of t-circle formation
COMPARTMENTS	4	2.2e-07	9.39e-06	DNA-dependent protein kinase complex
HPO	5	3.81e-07	1.17e-05	Reticulocytopenia
RCTM	6	3.89e-07	1.18e-05	DNA Damage/Telomere Stress Induced Senescence
HPO	6	3.89e-07	1.19e-05	Convex nasal ridge
NetworkNeighborAL	4	6.53e-08	1.2e-05	NIPBL role in DNA damage - Cornelia de Lange syndrome
InterPro	9	1.46e-08	1.5e-05	AAA+ ATPase domain
Function	4	1.53e-07	1.51e-05	5-flap endonuclease activity
Function	4	1.53e-07	1.51e-05	DNA/DNA annealing activity
HPO	7	5.29e-07	1.62e-05	Narrow face
WikiPathways	8	4.79e-07	1.7e-05	Breast cancer pathway
HPO	9	6.34e-07	1.94e-05	Neoplasm of the gastrointestinal tract
HPO	4	7.24e-07	2.2e-05	Complete duplication of thumb phalanx
HPO	9	7.33e-07	2.22e-05	Abnormality of the pancreas
HPO	6	7.71e-07	2.34e-05	Gastrointestinal atresia
HPO	8	7.89e-07	2.38e-05	Abnormality of the ovary
Process	4	3.07e-07	2.65e-05	Mitotic DNA replication checkpoint signaling
RCTM	4	9.27e-07	2.79e-05	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
RCTM	4	9.27e-07	2.79e-05	Removal of the Flap Intermediate
HPO	4	9.27e-07	2.79e-05	Complete duplication of phalanx of hand
RCTM	4	9.27e-07	2.79e-05	Polymerase switching
RCTM	4	9.27e-07	2.79e-05	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)
Process	47	3.28e-07	2.81e-05	Regulation of cellular metabolic process
Function	4	3.07e-07	2.92e-05	Four-way junction DNA binding
Function	4	3.07e-07	2.92e-05	G-quadruplex DNA binding
COMPARTMENTS	4	7.24e-07	2.97e-05	Lateral element
TISSUES	4	3.93e-08	3.18e-05	U2-OS cell
Process	5	3.81e-07	3.25e-05	Mismatch repair
Keyword	8	9.78e-07	3.29e-05	Dwarfism
InterPro	4	3.93e-08	3.53e-05	DNA clamp superfamily
InterPro	4	3.93e-08	3.53e-05	ERCC4 domain
InterPro	4	3.93e-08	3.53e-05	Restriction endonuclease type II-like
InterPro	8	5.37e-08	3.53e-05	Helicase superfamily 1/2, ATP-binding domain
InterPro	4	3.93e-08	3.53e-05	DNA helicase, ATP-dependent, RecQ type
InterPro	4	6.53e-08	3.61e-05	DNA polymerase III, clamp loader complex, gamma/delta/delta subunit, C-terminal
RCTM	6	1.32e-06	3.63e-05	SUMOylation of DNA damage response and repair proteins
HPO	43	1.23e-06	3.67e-05	Phenotypic abnormality
HPO	8	1.42e-06	4.22e-05	Neoplasm of the genitourinary tract
RCTM	5	1.73e-06	4.7e-05	Formation of Incision Complex in GG-NER
Component	4	9.27e-07	4.75e-05	Lateral element
HPO	13	1.67e-06	4.96e-05	Abnormal finger phalanx morphology
Component	3	1.52e-06	7.57e-05	Elg1 RFC-like complex
DISEASES	42	5.49e-07	8.4e-05	Disease of anatomical entity
HPO	6	2.97e-06	8.79e-05	Horseshoe kidney
HPO	4	3.16e-06	9.31e-05	Duplicated collecting system
Process	6	1.32e-06	0.00011	Intrinsic apoptotic signaling pathway in response to DNA damage
TISSUES	11	1.83e-07	0.00011	Cervical carcinoma cell
HPO	6	3.58e-06	0.00011	Lymphoma
HPO	5	3.82e-06	0.00011	Duplication of thumb phalanx
InterPro	4	2.2e-07	0.00011	RuvA domain 2-like
HPO	21	4.09e-06	0.00012	Erythrocyte indices
Keyword	6	4.04e-06	0.00012	Meiosis
Keyword	5	3.82e-06	0.00012	Exonuclease
Process	6	1.52e-06	0.00013	Protein autoubiquitination
Process	5	1.55e-06	0.00013	Somatic diversification of immune receptors via germline recombination within a single locus
HPO	12	4.55e-06	0.00013	Mean corpuscular hemoglobin concentration
Component	3	2.65e-06	0.00013	Mre11 complex
Component	3	2.65e-06	0.00013	DNA replication factor A complex
Function	3	1.52e-06	0.00013	DNA clamp loader activity
Function	6	1.52e-06	0.00013	Exonuclease activity
DISEASES	49	9.76e-07	0.00014	Disease
Process	5	1.92e-06	0.00015	Base-excision repair
HPO	3	6.31e-06	0.00018	Slender nose
HPO	5	6.4e-06	0.00019	Cachexia
Function	8	2.34e-06	0.00019	Protein C-terminus binding
HPO	5	6.94e-06	0.0002	Squamous cell carcinoma
Process	3	2.65e-06	0.00021	Positive regulation of t-circle formation
Process	3	2.65e-06	0.00021	DNA recombinase assembly
Process	3	2.65e-06	0.00021	Telomeric 3 overhang formation
Function	3	2.65e-06	0.00021	Telomeric D-loop binding
HPO	9	7.16e-06	0.00021	Sparse hair
Process	3	2.65e-06	0.00021	Cellular response to camptothecin
DISEASES	3	1.52e-06	0.00021	Fanconi anemia complementation group D1
Process	18	2.97e-06	0.00023	Regulation of organelle organization
Process	31	3.09e-06	0.00024	Positive regulation of cellular metabolic process
RCTM	7	9.63e-06	0.00026	SUMO E3 ligases SUMOylate target proteins
InterPro	7	6.33e-07	0.0003	Helicase, C-terminal
HPO	4	1.04e-05	0.0003	Esophageal atresia
Process	3	4.22e-06	0.00033	Strand invasion
Process	70	4.33e-06	0.00033	Regulation of biological process
Component	8	7.47e-06	0.00035	protein-DNA complex
DISEASES	3	2.65e-06	0.00036	Baller-Gerold syndrome
DISEASES	3	2.65e-06	0.00036	Rapadilino syndrome
Process	4	5.16e-06	0.00039	Histone H2A monoubiquitination
Process	4	5.16e-06	0.00039	Isotype switching
WikiPathways	5	1.18e-05	0.0004	G1 to S cell cycle control
HPO	4	1.5e-05	0.00043	Aplastic anemia
Process	5	5.9e-06	0.00044	Regulation of telomere maintenance via telomerase
Keyword	31	1.52e-05	0.00044	Acetylation
RCTM	5	1.66e-05	0.00044	Regulation of HSF1-mediated heat shock response
HPO	3	1.64e-05	0.00046	Ivory epiphyses
Function	4	6.01e-06	0.00047	Exodeoxyribonuclease activity, producing 5-phosphomonoesters
RCTM	11	1.85e-05	0.00048	Cell Cycle, Mitotic
RCTM	4	1.88e-05	0.00048	Activation of the pre-replicative complex
COMPARTMENTS	12	1.29e-05	0.00052	Microtubule organizing center
RCTM	4	2.1e-05	0.00053	Transcriptional Regulation by E2F6
DISEASES	3	4.22e-06	0.00054	Ataxia telangiectasia
DISEASES	5	4.57e-06	0.00056	Prostate cancer
HPO	4	2.1e-05	0.00059	Premature graying of hair
Process	28	8.15e-06	0.00061	Negative regulation of macromolecule metabolic process
Process	72	8.5e-06	0.00063	Biological regulation
Process	5	8.77e-06	0.00065	Cellular senescence
Process	3	8.99e-06	0.00066	Replication-born double-strand break repair via sister chromatid exchange
Process	3	8.99e-06	0.00066	Regulation of mitotic recombination
Process	3	8.99e-06	0.00066	Telomere maintenance via semi-conservative replication
Process	3	8.99e-06	0.00066	G-quadruplex DNA unwinding
Function	3	8.99e-06	0.00067	Oxidized purine DNA binding
Function	12	8.86e-06	0.00067	Chromatin binding
Process	7	9.63e-06	0.00069	Intrinsic apoptotic signaling pathway
HPO	5	2.43e-05	0.00069	Cutaneous photosensitivity
DISEASES	3	6.31e-06	0.00072	Li-Fraumeni syndrome
NetworkNeighborAL	3	4.22e-06	0.00074	DNA recombinase mediator complex
NetworkNeighborAL	3	4.22e-06	0.00074	DNA replication factor A complex, and DNA primase activity
HPO	8	2.8e-05	0.00079	Tooth agenesis
HPO	4	2.85e-05	0.0008	High pitched voice
RCTM	3	3.36e-05	0.00084	HSF1 activation
Process	3	1.23e-05	0.00087	DNA damage induced protein phosphorylation
Process	6	1.3e-05	0.00091	Blastocyst development
Function	3	1.23e-05	0.00091	5-3 DNA helicase activity
Function	3	1.23e-05	0.00091	Single-stranded DNA helicase activity
Function	3	1.23e-05	0.00091	Bubble DNA binding
Function	3	1.23e-05	0.00091	Single-stranded DNA endodeoxyribonuclease activity
Process	46	1.38e-05	0.00096	Positive regulation of biological process
Process	3	1.64e-05	0.0011	Protein K6-linked ubiquitination
InterPro	3	2.65e-06	0.0012	ATP-dependent DNA helicase RecQ, zinc-binding domain
HPO	10	4.17e-05	0.0012	External genital hypoplasia
HPO	6	4.42e-05	0.0012	Blepharophimosis
HPO	3	4.12e-05	0.0012	Pelvic kidney
TISSUES	17	2.97e-06	0.0012	Leukemia cell
COMPARTMENTS	20	3.36e-05	0.0013	Catalytic complex
InterPro	6	3.37e-06	0.0014	Nucleic acid-binding, OB-fold
HPO	8	4.89e-05	0.0014	Abnormal number of teeth
HPO	3	4.98e-05	0.0014	Absent earlobe
Process	5	2.01e-05	0.0014	Positive regulation of DNA recombination
InterPro	5	3.48e-06	0.0014	ATPase, AAA-type, core
COMPARTMENTS	10	3.96e-05	0.0015	Centrosome
Function	3	2.12e-05	0.0015	G-rich strand telomeric DNA binding
WikiPathways	6	4.59e-05	0.0015	Male infertility
HPO	4	5.8e-05	0.0016	Decreased adipose tissue
HPO	3	5.96e-05	0.0016	Hypoplastic pelvis
Process	9	2.31e-05	0.0016	Positive regulation of cell cycle
Process	3	2.69e-05	0.0018	Cellular response to hydroxyurea
Process	66	2.67e-05	0.0018	Regulation of cellular process
Process	4	2.85e-05	0.0019	Cellular response to alkaloid
WikiPathways	3	5.96e-05	0.0019	miRNAs involved in DNA damage response
HPO	9	7.68e-05	0.0021	Mean reticulocyte volume
Process	3	3.36e-05	0.0022	Mitotic DNA replication
Process	42	3.4e-05	0.0022	Positive regulation of cellular process
RCTM	12	9.38e-05	0.0023	Cellular responses to stress
Component	13	5.65e-05	0.0024	Microtubule organizing center
HPO	5	8.96e-05	0.0025	Sparse scalp hair
Component	4	6.29e-05	0.0026	Nuclear ubiquitin ligase complex
RCTM	2	0.00011	0.0026	Defective DNA double strand break response due to BRCA1 loss of function
RCTM	2	0.00011	0.0026	Defective DNA double strand break response due to BARD1 loss of function
HPO	3	9.63e-05	0.0026	Poikiloderma
Process	4	4.13e-05	0.0027	Negative regulation of DNA biosynthetic process
Function	44	4.09e-05	0.0027	Ion binding
HPO	7	0.00011	0.0031	Abnormal epiphysis morphology
Process	3	4.98e-05	0.0032	Inner cell mass cell proliferation
Process	5	5.02e-05	0.0033	Multicellular organism growth
HPO	6	0.00012	0.0033	Abnormal dental enamel morphology
HPO	4	0.00012	0.0033	Telangiectasia of the skin
Process	4	5.35e-05	0.0034	DNA damage response, signal transduction by p53 class mediator
Component	4	8.52e-05	0.0034	Male germ cell nucleus
HPO	3	0.00013	0.0035	Progeroid facial appearance
Process	5	5.56e-05	0.0036	Cellular response to UV
DISEASES	3	3.36e-05	0.0037	Seckel syndrome
Process	3	5.96e-05	0.0038	DNA strand elongation involved in DNA replication
RCTM	4	0.00017	0.0039	Meiotic synapsis
Process	5	6.14e-05	0.0039	Protein localization to chromosome
COMPARTMENTS	2	0.00011	0.004	RecFOR complex
HPO	14	0.00015	0.0041	Abnormal hair morphology
TISSUES	10	1.52e-05	0.0041	Lymphocytic leukemia cell
Process	5	6.45e-05	0.0041	Signal transduction by p53 class mediator
Component	2	0.00011	0.0043	ATR-ATRIP complex
Component	2	0.00011	0.0043	Rad51C-XRCC3 complex
Process	7	7.04e-05	0.0044	protein-DNA complex assembly
HPO	9	0.00016	0.0044	Hypoplastic male external genitalia
HPO	4	0.00018	0.0048	Embryonal neoplasm
Process	9	8.11e-05	0.005	Developmental growth
HPO	14	0.00019	0.0051	Abnormality of joint mobility
Process	3	8.28e-05	0.0051	Protein localization to chromosome, telomeric region
HPO	35	0.0002	0.0053	Hematological measurement
HPO	6	0.00021	0.0055	Abnormal nasal dorsum morphology
HPO	4	0.00022	0.0059	Abnormal T cell count
HPO	6	0.00022	0.006	Abnormal odontoid tissue morphology
Function	4	9.16e-05	0.006	3-5 exonuclease activity
HPO	13	0.00022	0.006	Failure to thrive
WikiPathways	5	0.0002	0.0061	Cell cycle
COMPARTMENTS	4	0.00017	0.0061	Nuclear ubiquitin ligase complex
RCTM	5	0.00027	0.0063	DNA Replication Pre-Initiation
WikiPathways	4	0.00022	0.0064	Pathways affected in adenoid cystic carcinoma
HPO	15	0.00024	0.0064	Hemoglobin measurement
Process	4	0.00011	0.0065	Male meiotic nuclear division
COMPARTMENTS	2	0.00018	0.0065	Nucleotide-excision repair factor 1 complex
HPO	6	0.00025	0.0067	Duplication of phalanx of hand
Process	2	0.00011	0.0067	Mitotic recombination-dependent replication fork processing
Process	5	0.00011	0.0067	Regulation of signal transduction by p53 class mediator
Process	2	0.00011	0.0067	Resolution of mitotic recombination intermediates
Process	2	0.00011	0.0067	Establishment of RNA localization to telomere
Process	2	0.00011	0.0067	Establishment of protein-containing complex localization to telomere
Process	2	0.00011	0.0067	Positive regulation of telomerase catalytic core complex assembly
Component	2	0.00018	0.0069	Nucleotide-excision repair factor 1 complex
Component	2	0.00018	0.0069	Replication fork protection complex
Component	2	0.00018	0.0069	Slx1-Slx4 complex
Component	2	0.00018	0.0069	Holliday junction resolvase complex
Component	2	0.00018	0.0069	ERCC4-ERCC1 complex
HPO	11	0.00027	0.007	Mean corpuscular hemoglobin
Function	2	0.00011	0.0071	DNA clamp unloader activity
Function	2	0.00011	0.0071	Telomeric G-quadruplex DNA binding
Function	2	0.00011	0.0071	Forked DNA-dependent helicase activity
HPO	2	0.00027	0.0071	Patchy demyelination of subcortical white matter
Pfam	3	2.65e-06	0.0072	RecQ zinc-binding
COMPARTMENTS	5	0.0002	0.0072	ATPase complex
Process	7	0.00012	0.0072	Positive regulation of cell cycle process
HPO	16	0.00028	0.0074	Myeloid white cell count
HPO	3	0.00029	0.0075	Uveitis
Function	3	0.00013	0.008	DNA polymerase binding
HPO	11	0.00034	0.0088	Eosinophil count
HPO	5	0.00034	0.009	Pallor
HPO	3	0.00035	0.009	Adipose tissue loss
HPO	3	0.00035	0.009	Non-Hodgkin lymphoma
Component	2	0.00027	0.0092	BRCA1-BARD1 complex
COMPARTMENTS	2	0.00027	0.0094	Rhp55-Rhp57 complex
COMPARTMENTS	2	0.00027	0.0094	Single-stranded DNA-binding protein complex
COMPARTMENTS	2	0.00027	0.0094	CENP-T-W-S-X complex
COMPARTMENTS	2	0.00027	0.0094	Replication fork protection complex
COMPARTMENTS	2	0.00027	0.0094	BRCA1-BARD1 complex
HPO	7	0.00037	0.0095	Abnormality of the scalp hair
Process	3	0.00016	0.0096	Negative regulation of telomere maintenance via telomerase
HPO	2	0.00038	0.0097	Widely spaced primary teeth
HPO	2	0.00038	0.0097	Hypoplasia of the primary teeth
HPO	3	0.00038	0.0098	Reduced subcutaneous adipose tissue
Process	11	0.00017	0.0098	Embryo development ending in birth or egg hatching
HPO	3	0.00038	0.0098	Osteosarcoma
HPO	6	0.0004	0.0102	Micropenis
Process	2	0.00018	0.0105	Replication fork reversal
Process	2	0.00018	0.0105	Telomeric DNA-containing double minutes formation
Process	2	0.00018	0.0105	Replication fork arrest
Component	10	0.00032	0.0105	Centrosome
Process	2	0.00018	0.0105	Negative regulation of protection from non-homologous end joining at telomere
HPO	3	0.00042	0.0106	Acute lymphoblastic leukemia
Function	2	0.00018	0.011	Flap-structured DNA binding
Function	2	0.00018	0.011	8-hydroxy-2-deoxyguanosine DNA binding
Process	4	0.0002	0.0112	Homologous chromosome segregation
Component	13	0.00036	0.0115	Nucleolus
DISEASES	2	0.00011	0.0116	Fanconi anemia complementation group T
DISEASES	2	0.00011	0.0116	Fanconi anemia complementation group I
DISEASES	2	0.00011	0.0116	Fanconi anemia complementation group Q
DISEASES	2	0.00011	0.0116	XFE progeroid syndrome
Process	5	0.00021	0.0119	Positive regulation of protein ubiquitination
COMPARTMENTS	2	0.00038	0.0122	Rad51C-XRCC3 complex
HPO	3	0.00049	0.0125	Nephroblastoma
HPO	2	0.0005	0.0127	Normal pressure hydrocephalus
HPO	2	0.0005	0.0127	Increased cellular sensitivity to UV light
HPO	2	0.0005	0.0127	Peripheral dysmyelination
HPO	2	0.0005	0.0127	Square pelvis bone
HPO	3	0.00054	0.0134	Abnormal proportion of CD4-positive T cells
HPO	5	0.00055	0.0137	Craniosynostosis
HPO	15	0.00056	0.0139	Abnormal musculoskeletal physiology
HPO	7	0.00057	0.0141	Short neck
Process	3	0.00026	0.0145	Mitochondrial genome maintenance
Process	3	0.00026	0.0145	Positive regulation of protein autophosphorylation
SMART	2	0.00011	0.0149	This DNA-binding domain is found in the RecQ helicase among others and has a helix-turn-helix structure. The RQC domain, found only in RecQ family enzymes, is a high affinity G4 DNA binding domain PUBMED:16530788.
Process	2	0.00027	0.0151	Cellular response to cisplatin
Process	5	0.00027	0.0151	Regulation of chromosome segregation
Process	2	0.00027	0.0151	Meiotic DNA double-strand break processing
Process	2	0.00027	0.0151	Nucleotide-excision repair, DNA incision, 5-to lesion
HPO	4	0.00061	0.0152	Renal hypoplasia
Process	5	0.00028	0.0154	Positive regulation of DNA repair
HPO	2	0.00064	0.0159	Ivory epiphyses of the phalanges of the hand
Function	2	0.00027	0.0161	Exodeoxyribonuclease III activity
Function	2	0.00027	0.0161	MutLalpha complex binding
COMPARTMENTS	2	0.0005	0.0161	RQC complex
HPO	3	0.00067	0.0167	Abnormal epiphysis morphology of the phalanges of the hand
DISEASES	2	0.00018	0.0177	Peritoneal carcinoma
Process	8	0.00033	0.0179	In utero embryonic development
HPO	10	0.00076	0.0186	Abnormal hair quantity
COMPARTMENTS	2	0.00064	0.0203	BRCA1-A complex
SMART	2	0.00018	0.0212	Helicase and RNase D C-terminal
HPO	5	0.00088	0.0215	Renal agenesis
Function	2	0.00038	0.0219	ATP-dependent DNA/DNA annealing activity
Function	2	0.00038	0.0219	DNA translocase activity
Process	3	0.00042	0.0224	Positive regulation of cell cycle G2/M phase transition
Process	11	0.00043	0.0232	Gamete generation
HPO	5	0.00095	0.0232	Aplasia/Hypoplasia of the skin
HPO	2	0.00098	0.0239	Aplasia of metacarpal bones
HPO	4	0.00098	0.0239	Renal neoplasm
HPO	2	0.00098	0.0239	Loss of facial adipose tissue
Process	3	0.00045	0.0243	Intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
Process	3	0.00045	0.0243	Mitotic G1 DNA damage checkpoint signaling
HPO	4	0.001	0.0246	Prominent nose
HPO	3	0.001	0.0246	Abnormality of the radial head
Process	5	0.00047	0.0251	Regulation of nuclear division
HPO	4	0.0011	0.0254	Hypoplasia of teeth
Process	8	0.00048	0.0256	Cellular process involved in reproduction in multicellular organism
Component	2	0.0008	0.0257	BRCA1-A complex
DISEASES	2	0.00027	0.0259	Xeroderma pigmentosum group F
DISEASES	2	0.00027	0.0259	Sporadic breast cancer
Process	6	0.00049	0.026	Gonad development
Process	2	0.0005	0.0263	Double-strand break repair involved in meiotic recombination
Process	2	0.0005	0.0263	Response to glycoside
Process	2	0.0005	0.0263	Regulation of CD40 signaling pathway
HPO	19	0.0011	0.0264	Leukocyte count
SMART	3	0.00026	0.0265	Forkhead associated domain
Process	4	0.00052	0.0267	Somite development
HPO	2	0.0012	0.0281	Microtia, third degree
Process	10	0.00055	0.0284	Chordate embryonic development
HPO	4	0.0012	0.0289	Dental malocclusion
HPO	14	0.0012	0.0295	Granulocyte count
Process	3	0.00058	0.0297	Postreplication repair
TISSUES	24	0.00014	0.03	Organism form
TISSUES	23	0.00014	0.03	Embryonic structure
HPO	3	0.0013	0.0308	Keratinocyte carcinoma
Keyword	5	0.0011	0.0316	Tumor suppressor
COMPARTMENTS	6	0.001	0.0321	Ubiquitin ligase complex
HPO	3	0.0014	0.0325	Intestinal atresia
HPO	3	0.0014	0.0325	Short chin
HPO	2	0.0014	0.0326	Annular pancreas
HPO	2	0.0014	0.0326	Delayed eruption of primary teeth
HPO	2	0.0014	0.0326	Anotia
Process	2	0.00064	0.0329	Positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage
Process	22	0.00065	0.0331	Cellular component assembly
HPO	6	0.0015	0.0341	Delayed skeletal maturation
SMART	2	0.0005	0.0345	The FATC domain is named after FRAP, ATM, TRRAP C-terminal (PMID:10782091). The solution structure of the FATC domain suggests it plays a role in redox-dependent structural and cellular stability (PMID:15772072).
SMART	2	0.0005	0.0345	Helix-hairpin-helix DNA-binding motif class 1
SMART	2	0.00038	0.0345	Helix-hairpin-helix class 2 (Pol1 family) motifs
SMART	2	0.00038	0.0345	Xeroderma pigmentosum G I-region
SMART	2	0.00038	0.0345	Xeroderma pigmentosum G N-region
DISEASES	2	0.00038	0.0347	Bilateral breast cancer
DISEASES	2	0.00038	0.0347	Male breast cancer
DISEASES	2	0.00038	0.0347	Serous cystadenocarcinoma
DISEASES	2	0.00038	0.0347	Breast carcinoma in situ
HPO	5	0.0015	0.0349	Subcutaneous hemorrhage
HPO	4	0.0015	0.0356	Abnormal limb epiphysis morphology
HPO	7	0.0015	0.0356	Hypoplasia of penis
HPO	5	0.0015	0.0356	Abnormal adipose tissue morphology
HPO	3	0.0015	0.0356	Mild global developmental delay
Keyword	6	0.0013	0.0358	Mitosis
HPO	11	0.0016	0.0363	Reticulocyte measurement
Function	2	0.00064	0.0365	Double-stranded telomeric DNA binding
HPO	4	0.0016	0.0375	Microtia
Keyword	7	0.0015	0.0379	Cell division
Process	3	0.00078	0.0394	Positive regulation of double-strand break repair via homologous recombination
Process	3	0.00078	0.0394	Regulation of intrinsic apoptotic signaling pathway in response to DNA damage
Process	23	0.00078	0.0394	Protein modification process
Keyword	2	0.0016	0.04	Progressive external ophthalmoplegia
Process	2	0.0008	0.0402	Meiotic cell cycle checkpoint signaling
Process	2	0.0008	0.0402	Histone H2A K63-linked deubiquitination
HPO	6	0.0018	0.0405	Abnormality of dental structure
InterPro	2	0.00011	0.0411	Rad9/Ddc1
HPO	6	0.0018	0.0411	Abnormality of cranial sutures
InterPro	2	0.00011	0.0411	Rad9
InterPro	2	0.00011	0.0411	RQC domain
Process	3	0.00083	0.0414	Positive regulation of DNA replication
COMPARTMENTS	2	0.0014	0.0418	Nuclear inclusion body
DISEASES	2	0.0005	0.042	Fallopian tube carcinoma
DISEASES	2	0.0005	0.042	Female breast cancer
RCTM	2	0.0018	0.0422	Telomere C-strand synthesis initiation
RCTM	2	0.0018	0.0422	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
HPO	23	0.0019	0.0423	Complete blood cell count
RCTM	3	0.0019	0.0424	Deposition of new CENPA-containing nucleosomes at the centromere
HPO	3	0.0019	0.0432	Nose morphology measurement
Process	4	0.00088	0.0433	Female gonad development
Process	3	0.00089	0.0439	DNA synthesis involved in DNA repair
Process	4	0.00091	0.0446	Cellular response to alcohol
HPO	3	0.002	0.0453	Neuroepithelial neoplasm
HPO	3	0.002	0.0453	Bronchitis
Process	3	0.00095	0.0466	Sister chromatid cohesion
WikiPathways	4	0.0017	0.0468	CKAP4 signaling pathway map
HPO	2	0.0021	0.0476	Chromosomal breakage induced by ionizing radiation
HPO	2	0.0021	0.0476	Bird-like facies
Process	16	0.00099	0.0482	Regulation of protein modification process
COMPARTMENTS	11	0.0016	0.049	Transferase complex
Process	9	0.001	0.0491	Positive regulation of transferase activity
HPO	3	0.0022	0.0493	Nevus count
Component	2	0.0016	0.0498	Nuclear inclusion body
